ProKidney Corp. (PROK)
ProKidney Corp., a clinical-stage biotechnology, engages in developing cellular therapy candidates. It is developing Renal Autologous Cell Therapy, an autologous homologous cell admixture that is in a Phase III development program, as well as Phase II clinical trials for the treatment of moderate to severe diabetic kidney disease; and Phase I clinical trial for patients with congenital anomalies of the kidney and urinary tract. The company was founded in 2015 and is headquartered in Winston-Salem, North Carolina.
$715.50M
Dr. Timothy A. Bertram D.V.M., Ph.D.
59.00
Winston-Salem, NC
Jun 30, 2021
-4.12
$-0.60
9.94
19.04
0.00%
-1.15
0.01
-0.09
0.00
18.54
-21.59%
8.17%
Similar stocks (19)
Vaxcyte, Inc.
PCVX
Cerevel Therapeutics Holdings, Inc.
CERE
Revolution Medicines, Inc.
RVMD
Arcellx, Inc.
ACLX
Protagonist Therapeutics, Inc.
PTGX
Edgewise Therapeutics, Inc.
EWTX
Arvinas, Inc.
ARVN
Kura Oncology, Inc.
KURA
Relay Therapeutics, Inc.
RLAY
Erasca, Inc.
ERAS
Replimune Group, Inc.
REPL
Stoke Therapeutics, Inc.
STOK
Pliant Therapeutics, Inc.
PLRX
Third Harmonic Bio, Inc.
THRD
Monte Rosa Therapeutics, Inc.
GLUE
Lyell Immunopharma, Inc.
LYEL
Black Diamond Therapeutics, Inc.
BDTX
Ventyx Biosciences, Inc.
VTYX
PMV Pharmaceuticals, Inc.
PMVP
ETF Exposure (23)
Vanguard Russell 2000 Growth Index Fund
VTWG
0.01%
Vanguard Russell 2000 Index Fund
VTWO
0.01%
iShares Russell 2000 Growth ETF
IWO
0.00911%
iShares Russell 2000 ETF
IWM
0.00573%
iShares Russell 2000 Value ETF
IWN
0.00284%
ProShares Ultra Russell2000
UWM
0.0022126603591077786%
Schwab U.S. Small-Cap ETF
SCHA
0.0018533472%
ALPS Medical Breakthroughs ETF
SBIO
0.0011%
ProShares UltraPro Russell2000
URTY
0.001090847143176888%
ProShares Hedge Replication ETF
HDG
9.274873161181805e-4%
iShares Russell 3000 ETF
IWV
2.7e-4%
Vanguard Balanced Index Fund Institutional Shares
VBAIX
0%
Vanguard Balanced Index Fund Admiral Shares
VBIAX
0%
Vanguard Balanced Index Fund
VBINX
0%
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0%
Vanguard Institutional Total Stock Market Index Fund Institutional Shares
VITNX
0%
Vanguard Institutional Total Stock Market Index Fund
VITPX
0%
Vanguard Total Stock Market Index Fund
VITSX
0%
Vanguard Russell 3000 Index Fund
VTHR
0%
Vanguard Total Stock Market Index Fund
VTI
0%
Vanguard Total Stock Market Index Fund
VTSAX
0%
Vanguard Russell 2000 Value Index Fund
VTWV
0%
Vanguard Extended Market Index Fund
VXF
0%
Similar stocks (19)
Vaxcyte, Inc.
PCVX
Cerevel Therapeutics Holdings, Inc.
CERE
Revolution Medicines, Inc.
RVMD
Arcellx, Inc.
ACLX
Protagonist Therapeutics, Inc.
PTGX
Edgewise Therapeutics, Inc.
EWTX
Arvinas, Inc.
ARVN
Kura Oncology, Inc.
KURA
Relay Therapeutics, Inc.
RLAY
Erasca, Inc.
ERAS
Replimune Group, Inc.
REPL
Stoke Therapeutics, Inc.
STOK
Pliant Therapeutics, Inc.
PLRX
Third Harmonic Bio, Inc.
THRD
Monte Rosa Therapeutics, Inc.
GLUE
Lyell Immunopharma, Inc.
LYEL
Black Diamond Therapeutics, Inc.
BDTX
Ventyx Biosciences, Inc.
VTYX
PMV Pharmaceuticals, Inc.
PMVP
ETF Exposure (23)
Vanguard Russell 2000 Growth Index Fund
VTWG
0.01%
Vanguard Russell 2000 Index Fund
VTWO
0.01%
iShares Russell 2000 Growth ETF
IWO
0.00911%
iShares Russell 2000 ETF
IWM
0.00573%
iShares Russell 2000 Value ETF
IWN
0.00284%
ProShares Ultra Russell2000
UWM
0.0022126603591077786%
Schwab U.S. Small-Cap ETF
SCHA
0.0018533472%
ALPS Medical Breakthroughs ETF
SBIO
0.0011%
ProShares UltraPro Russell2000
URTY
0.001090847143176888%
ProShares Hedge Replication ETF
HDG
9.274873161181805e-4%
iShares Russell 3000 ETF
IWV
2.7e-4%
Vanguard Balanced Index Fund Institutional Shares
VBAIX
0%
Vanguard Balanced Index Fund Admiral Shares
VBIAX
0%
Vanguard Balanced Index Fund
VBINX
0%
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0%
Vanguard Institutional Total Stock Market Index Fund Institutional Shares
VITNX
0%
Vanguard Institutional Total Stock Market Index Fund
VITPX
0%
Vanguard Total Stock Market Index Fund
VITSX
0%
Vanguard Russell 3000 Index Fund
VTHR
0%
Vanguard Total Stock Market Index Fund
VTI
0%
Vanguard Total Stock Market Index Fund
VTSAX
0%
Vanguard Russell 2000 Value Index Fund
VTWV
0%
Vanguard Extended Market Index Fund
VXF
0%